Chris Mason, MD, PhD, FRCS, FMedSci
Chief Scientific Officer
Chris is a clinician-scientist with more than 25 years of cell and gene therapy experience spanning R&D, clinical medicine, bioprocessing and commercialization. He works to train the next generation of world-class scientists as a professor of cell and gene therapy at University College London and reviews cutting-edge research from around the world as senior editor of the journals Cell and Gene Therapy Insights and Regenerative Medicine. Chris was instrumental in the founding of the Alliance for Regenerative Medicine (ARM), the UK-Israel Science Council and the London Regenerative Medicine Network. He serves on the board of directors for Krystal Biotech and OriBiotech, and is a member of the scientific advisory board for several public and private companies, the UK Cell & Gene Therapy Catapult, and the Canadian Centre for the Commercialization of Regenerative Medicine.